Literature DB >> 11801639

Human anergic CD4+ T cells can act as suppressor cells by affecting autologous dendritic cell conditioning and survival.

Loredana Frasca1, Cristiano Scottà, Giovanna Lombardi, Enza Piccolella.   

Abstract

T cell suppression exerted by regulatory T cells represents a well-established phenomenon, but the mechanisms involved are still a matter of debate. Recent data suggest that anergic T cells can suppress responder T cell activation by inhibiting Ag presentation by dendritic cells (DC). In this study, we focused our attention on the mechanisms that regulate the susceptibility of DC to suppressive signals and analyzed the fate of DC and responder T cells. To address this issue, we have cocultured human alloreactive or Ag-specific CD4+ T cell clones, rendered anergic by incubation with immobilized anti-CD3 Ab, with autologous DC and responder T cells. We show that anergic T cells affect either Ag-presenting functions or survival of DC, depending whether immature or mature DC are used as APC. Indeed, MHC and costimulatory molecule expression on immature DC activated by responder T cells is inhibited, while apoptotic programs are induced in mature DC and in turn in responder T cells. Ligation of CD95 by CD95L expressed on anergic T cells in the absence of CD40-CD40L (CD154) interaction are critical parameters in eliciting apoptosis in both DC and responder T cells. In conclusion, these findings indicate that the defective activation of CD40 on DC by CD95L+ CD154-defective anergic T cells could be the primary event in determining T cell suppression and support the role of CD40 signaling in regulating both conditioning and survival of DC.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11801639     DOI: 10.4049/jimmunol.168.3.1060

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  6 in total

Review 1.  Targeting T lymphocytes for immune monitoring and intervention in autoimmune diabetes.

Authors:  Roberto Mallone; Gerald T Nepom
Journal:  Am J Ther       Date:  2005 Nov-Dec       Impact factor: 2.688

2.  Functional avidity directs T-cell fate in autoreactive CD4+ T cells.

Authors:  Roberto Mallone; Sharon A Kochik; Helena Reijonen; Bryan Carson; Steven F Ziegler; William W Kwok; Gerald T Nepom
Journal:  Blood       Date:  2005-07-19       Impact factor: 22.113

Review 3.  Immunoregulatory cells for transplantation tolerance and graft-versus-leukemia effect.

Authors:  Masahiro Imamura; Junji Tanaka
Journal:  Int J Hematol       Date:  2003-10       Impact factor: 2.490

4.  In vitro induction of regulatory T cells by anti-CD3 antibody in humans.

Authors:  Michal Abraham; Arnon Karni; Adi Dembinsky; Ariel Miller; Roopali Gandhi; David Anderson; Howard L Weiner
Journal:  J Autoimmun       Date:  2008 Feb-Mar       Impact factor: 7.094

5.  Modulation of monocyte/macrophage function by human CD4+CD25+ regulatory T cells.

Authors:  Leonie S Taams; Jocea M R van Amelsfort; Machteld M Tiemessen; Kim M G Jacobs; Esther C de Jong; Arne N Akbar; Johannes W J Bijlsma; Floris P J G Lafeber
Journal:  Hum Immunol       Date:  2005-03       Impact factor: 2.850

6.  CD4+CD25+ T cells protect against experimentally induced asthma and alter pulmonary dendritic cell phenotype and function.

Authors:  Ian P Lewkowich; Nancy S Herman; Kathleen W Schleifer; Matthew P Dance; Brian L Chen; Krista M Dienger; Alyssa A Sproles; Jaimin S Shah; Jörg Köhl; Yasmine Belkaid; Marsha Wills-Karp
Journal:  J Exp Med       Date:  2005-11-28       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.